Omada Health stock
OMDANASDAQHealthcareISIN US68170A1088
44Score 44 out of 100, Weak
Price and trend
43 / 100
Price history
−31% in one yearThe chart shows daily closes over 1 year, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 17% below it.
Since July 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Sharply down: the price has fallen very quickly lately (RSI 28).
The price is 41% below its 52-week high. Largest decline in 1 year: 59% (October 2025 to February 2026).
Chart figures for advanced users
- SMA 50$19.46
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$17.72
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)28
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$10.94
- The lowest closing price of the last twelve months.
- Resistance$24.99
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Omada Health belongs to the Medical (Healthcare Information Services) industry (United States) and, with a market value of $911.95M, is number 15 of 25 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $260.21M (up 53.2% year on year) and a loss of $12.78M.
- For fiscal 2026, analysts expect on average revenue of $343.27M (up 31.9%) and adjusted earnings per share of $0.55.
Show more
- MEQIRI Score 44 out of 100 (Weak): rank 486 of 714 in Healthcare, median 53.
- Our model puts fair value at $14.78, with the price 3% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 42.9% a year since 2022, Medical (Healthcare Information Services) median 16.5%.Growth 70
- More cash than debtCash $243.15M, financial debt $0.Stability 55
- Analysts expect strong earnings growthUp 30% a year through 2028 (estimates from 4 analysts).Growth 70
Weaknesses
- Volatile share priceVolatility 65% a year over the last 12 months.Stability 55
Its standout strength is growth, while valuation and momentum hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 40 to 44.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
Fairly valuedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $9.85 and expensive above $29.56 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $20.56 (cash-flow model) and $8.99 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $13.00, at 7.8% it would be $17.45.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (43).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 43.3% on the twelve months before. Revenue has grown strongly since 2022, at around 43% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 66%, operating −5%, net −5%. Last 12 months: net 4%.
Debt & balance sheet
latest quarterNo financial debt is reported on the balance sheet.
Earnings
- Next earnings
- 4 Mar 2027in 112 days
- Last reported
- 5 Nov 2026EPS reported $0.10 (expected $0.09)above expectations
Analyst estimates
Analysts have raised their 2026 earnings estimate by 66.2% since 15 Oct 2026.
- Earnings per share
- $0.55+66.2%
- Revenue
- $343.27M+1.3%
- Earnings per share
- $0.61+37.8%
- Revenue
- $411.34M+0.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +23.9%2026 guidance raised: revenue of $334 million to $340 million (previously $322 million to $330 million) and adjusted EBITDA of $21 million to $27 million (previously $14 million to $20 million).
“We are raising full year adjusted EBITDA guidance to $21 million-$27 million, up from prior guidance of $14 million-$20 million.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 4 insiders sold, $7.63M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Duffy Sean P.Sale
4 Nov 2026, Chief Executive Officer
- Shares
- 12,944
- Price
- $19.22
- Value
- $248,731
- Duffy Sean P.Sale
1 Oct 2026, Chief Executive Officer
- Shares
- 17,258
- Price
- $20.68
- Value
- $356,915
- Duffy Sean P.Sale
10 Sept 2026, Chief Executive Officer
- Shares
- 14,960
- Price
- $21.87
- Value
- $327,197
Show 38 more
- Cook Steven L.Sale
10 Sept 2026, Chief Financial Officer
- Shares
- 6,800
- Price
- $21.86
- Value
- $148,640
- Shao Wei-LiSale
10 Sept 2026, President
- Shares
- 4,036
- Price
- $21.85
- Value
- $88,206
- Gracey CraigSale
9 Sept 2026, Chief Accounting Officer
- Shares
- 644
- Price
- $21.73
- Value
- $13,995
- Duffy Sean P.Sale
1 Sept 2026, Chief Executive Officer
- Shares
- 21,572
- Price
- $23.62
- Value
- $509,465
- Cook Steven L.Sale
27 Aug 2026, Chief Financial Officer
- Shares
- 1,108
- Price
- $25.00
- Value
- $27,700
- Shao Wei-LiSale
12 Aug 2026, President
- Shares
- 9,418
- Price
- $25.02
- Value
- $235,607
- Cook Steven L.Sale
11 Aug 2026, Chief Financial Officer
- Shares
- 1,607
- Price
- $25.01
- Value
- $40,197
- Cook Steven L.Sale
10 Aug 2026, Chief Financial Officer
- Shares
- 15,235
- Price
- $25.03
- Value
- $381,350
- Gracey CraigSale
10 Aug 2026, Chief Accounting Officer
- Shares
- 1,042
- Price
- $25.00
- Value
- $26,050
- Duffy Sean P.Sale
10 Aug 2026, Chief Executive Officer
- Shares
- 12,942
- Price
- $24.81
- Value
- $321,059
- Duffy Sean P.Sale
7 Aug 2026, Chief Executive Officer
- Shares
- 8,628
- Price
- $21.85
- Value
- $188,522
- Duffy Sean P.Sale
3 Aug 2026, Chief Executive Officer
- Shares
- 12,944
- Price
- $20.40
- Value
- $264,007
- Cook Steven L.Sale
15 Jul 2026, Chief Financial Officer
- Shares
- 12,150
- Price
- $24.01
- Value
- $291,774
- Gracey CraigSale
13 Jul 2026, Chief Accounting Officer
- Shares
- 1,041
- Price
- $24.00
- Value
- $24,984
- Cook Steven L.Sale
13 Jul 2026, Chief Financial Officer
- Shares
- 5,800
- Price
- $24.00
- Value
- $139,206
- Cook Steven L.Sale
7 Jul 2026, Chief Financial Officer
- Shares
- 12,337
- Price
- $23.09
- Value
- $284,840
- Cook Steven L.Sale
1 Jul 2026, Chief Financial Officer
- Shares
- 23,263
- Price
- $22.76
- Value
- $529,501
- Duffy Sean P.Sale
1 Jul 2026, Chief Executive Officer
- Shares
- 25,886
- Price
- $22.68
- Value
- $587,223
- Gracey CraigSale
1 Jul 2026, Chief Accounting Officer
- Shares
- 637
- Price
- $23.00
- Value
- $14,651
- Gracey CraigSale
30 Jun 2026, Chief Accounting Officer
- Shares
- 405
- Price
- $22.00
- Value
- $8,910
- Cook Steven L.Sale
30 Jun 2026, Chief Financial Officer
- Shares
- 300
- Price
- $22.00
- Value
- $6,600
- Gracey CraigSale
29 Jun 2026, Chief Accounting Officer
- Shares
- 2,083
- Price
- $21.00
- Value
- $43,743
- Cook Steven L.Sale
29 Jun 2026, Chief Financial Officer
- Shares
- 17,950
- Price
- $21.07
- Value
- $378,167
- Duffy Sean P.Sale
26 Jun 2026, Chief Executive Officer
- Shares
- 14,158
- Price
- $20.00
- Value
- $283,176
- Gracey CraigSale
26 Jun 2026, Chief Accounting Officer
- Shares
- 2,084
- Price
- $20.00
- Value
- $41,680
- Cook Steven L.Sale
26 Jun 2026, Chief Financial Officer
- Shares
- 33,000
- Price
- $19.89
- Value
- $656,449
- Duffy Sean P.Sale
25 Jun 2026, Chief Executive Officer
- Shares
- 300
- Price
- $19.00
- Value
- $5,701
- Cook Steven L.Sale
25 Jun 2026, Chief Financial Officer
- Shares
- 300
- Price
- $19.00
- Value
- $5,701
- Duffy Sean P.Sale
24 Jun 2026, Chief Executive Officer
- Shares
- 2,800
- Price
- $19.01
- Value
- $53,239
- Gracey CraigSale
24 Jun 2026, Chief Accounting Officer
- Shares
- 2,083
- Price
- $19.01
- Value
- $39,602
- Cook Steven L.Sale
24 Jun 2026, Chief Financial Officer
- Shares
- 2,600
- Price
- $19.02
- Value
- $49,445
- Gracey CraigSale
22 Jun 2026, Chief Accounting Officer
- Shares
- 2,083
- Price
- $18.00
- Value
- $37,494
- Cook Steven L.Sale
22 Jun 2026, Chief Financial Officer
- Shares
- 17,950
- Price
- $18.13
- Value
- $325,394
- Duffy Sean P.Sale
16 Jun 2026, Chief Executive Officer
- Shares
- 14,960
- Price
- $17.36
- Value
- $259,712
- Cook Steven L.Sale
15 Jun 2026, Chief Financial Officer
- Shares
- 6,800
- Price
- $17.23
- Value
- $117,184
- Gracey CraigSale
12 Jun 2026, Chief Accounting Officer
- Shares
- 6,894
- Price
- $17.42
- Value
- $120,123
- Shao Wei-LiSale
12 Jun 2026, President
- Shares
- 4,037
- Price
- $17.24
- Value
- $69,601
- Shao Wei-LiSale
12 Jun 2026, President
- Shares
- 4,589
- Price
- $17.24
- Value
- $79,118
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Omada Health
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
714 rated companies in Healthcare
- This company
- 44
- Sector median
- 53
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Medical (Healthcare Information Services)
The next larger and next smaller companies by market value
- CertaraCERT $1.79B54
- OmnicellOMCL $1.64B50
- Teladoc HealthTDOC $1.63B47
- GoodRx HoldingsGDRX $1.25B58
- HealthStreamHSTM $883.61M62
- PhreesiaPHR $795.13M55
- SOPHiA GENETICSSOPH $635.9M47
- RaySearch LaboratoriesRAY-B.ST $587.54M66
ETFs that hold Omada Health
Held by 7 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Global X Telemedicine & Digital Health UCITS ETFDDOC | 0.52% | 0.68% | €5.31M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.03% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.02% | 0.30% | €2.17B |
Show 3 more
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.00% | 0.25% | €175.89M |
| State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)SPYI | 0.00% | 0.17% | €8.6B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 11 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.